Neuron Culture's Top Ten from September

Never know what'll top the charts. Top post was a post I put up in January, "Pfizer takes $2.3 billion offl-label marketing fine." That post reported the news (via FiercePharma) that Pfizer had tucked away in its financial disclosure forms a $2.3 billion charge to end the federal investigation into allegations of off-label promotions of its Cox-2 painkillers, including Bextra. (Lot of money ... but it didn't quite wipe out the company's 2008 net income.) The company had set aside the money as part of a deal it was negotiating Justiice. Finalizing the deal, however, took until September. At that point, the Dept of Justice announced it in a splashy press conference. Because my post was was one of the few things already on the interwebz before Justice held its news conference, the Google rush shot it toward the top of the search results. Sometimes big news is 8 months old.

Other hits of the month:

Embargo? Embargo? The case of the missing swine flu paper

How Pfizer's $2.3B criminal settlement proves Obama wants to 'federalize' healthcare

PTSD: Two new programs; two big ignored questions

Morning Dip - Depression doubles; swine flu packs for a move north

53-inch penises, other self-destruction, & viruses bad & good

We're Number 37 - The "Rock Tank" analysis of the healthcare reform debate Very entertaining. You should watch it again.

What the Public Thinks of Public Schools

Neuroskeptic: Trauma Alters Brain Function... So What?

More like this

Close on the heels of Lilly's $1.42 billion penalty for off-label marketing comes the news that Pfizer paid out $2.3 billion to settle similar allegations. From FiercePharma News of the Pfizer-Wyeth merger this morning drowned out some not so good news for the company. Just after announcing its…
You can't make this stuff up. As PharmaGossip (among others, including the Times) reportst, a drug company pays $2.3 billion in fines to settle charges of unprecedented seriousness about practices that directly put patients at risk, and that came out of a four-year federal investigation. And some…
The odd thing about the Pfizer story is that it is old news.  Fierce Pharma href="">wrote about it on 26 January 2009, and Neuron Culture href="…
Pharma giant Pfizer got bigger on Monday, purchasing Wyeth Pharamceuticals for $65 billion in one of the few big business moves to get funding lately. This comes after several years of aggressive cost-cutting and huge layoffs at Pfizer, and was announced as the company released an annual report…